54 related articles for article (PubMed ID: 24767392)
1. Utility of glucagon stimulation test in type 1 diabetes after pancreas transplantation.
Hiratsuka I; Suzuki A; Kondo-Ando M; Hirai H; Maeda Y; Sekiguchi-Ueda S; Shibata M; Takayanagi T; Makino M; Fukami N; Itoh T; Sasaki H; Kusaka M; Kenmochi T; Hoshinaga K; Itoh M
Transplant Proc; 2014 Apr; 46(3):967-9. PubMed ID: 24767392
[TBL] [Abstract][Full Text] [Related]
2. Increment of C-peptide after glucagon injection determines the progressive nature of Japanese type 2 diabetes: a long-term follow-up study.
Fukui T; Oono K; Hara N; Yamamoto T; Nagashima M; Naito H; Hirano T
Endocr J; 2013; 60(6):715-24. PubMed ID: 23386398
[TBL] [Abstract][Full Text] [Related]
3. Native pancreatic alpha-cell adaptation in streptozotocin-induced diabetic primates: importance for pig islet xenotransplantation.
Dufrane D; Maillart JF; Aouassar N; Goebbels RM; Guiot Y; Gianello P
Xenotransplantation; 2009; 16(3):152-63. PubMed ID: 19566655
[TBL] [Abstract][Full Text] [Related]
4. Fasting and postprandial liver glycogen content in patients with type 1 diabetes mellitus after successful pancreas-kidney transplantation with systemic venous insulin delivery.
Stadler M; Krššák M; Jankovic D; Göbl C; Winhofer Y; Pacini G; Bischof M; Haidinger M; Saemann M; Mühlbacher F; Korbonits M; Baumgartner-Parzer SM; Luger A; Prager R; Anderwald CH; Krebs M
Clin Endocrinol (Oxf); 2014 Feb; 80(2):208-13. PubMed ID: 23302039
[TBL] [Abstract][Full Text] [Related]
5. Normal meal tolerance test is preferable to the glucagon stimulation test in patients with type 2 diabetes that are not in a hyperglycemic state: Comparison with the change of C-peptide immunoreactivity.
Fujioka Y; Okura T; Sumi K; Matsumoto K; Shoji K; Nakamura R; Matsuzawa K; Izawa S; Kato M; Taniguchi S; Yamamoto K
J Diabetes Investig; 2018 Mar; 9(2):274-278. PubMed ID: 28494143
[TBL] [Abstract][Full Text] [Related]
6. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
7. Glucagon Test Is a Useful Predictor of Withdrawal From Insulin Therapy in Subjects With Type 2 Diabetes Mellitus.
Iwamoto Y; Kimura T; Tatsumi F; Sugisaki T; Kubo M; Nakao E; Dan K; Wamata R; Iwamoto H; Takahashi K; Sanada J; Fushimi Y; Katakura Y; Shimoda M; Nakanishi S; Mune T; Kaku K; Kaneto H
Front Endocrinol (Lausanne); 2022; 13():871660. PubMed ID: 35574023
[TBL] [Abstract][Full Text] [Related]
8. [Clinical usefulness of the glucagon test in the study of pancreatic islet cell function].
Llorente I; Goñi MJ; Forga L; Monreal M; Lizcano F; Moncada E
Rev Med Univ Navarra; 1992; 37(1):25-9. PubMed ID: 1626165
[TBL] [Abstract][Full Text] [Related]
9. Effects of pancreas transplantation on postprandial glucose metabolism.
Katz H; Homan M; Velosa J; Robertson P; Rizza R
N Engl J Med; 1991 Oct; 325(18):1278-83. PubMed ID: 1922222
[TBL] [Abstract][Full Text] [Related]
10. [Function of pancreas transplants in increased metabolic stress].
Teuscher AU; Seaquist ER; Barrou Z; Kendall DM; Robertson RP
Swiss Surg; 1995; (4):188-92. PubMed ID: 9156819
[TBL] [Abstract][Full Text] [Related]
11. Utility of indices using C-peptide levels for indication of insulin therapy to achieve good glycemic control in Japanese patients with type 2 diabetes.
Funakoshi S; Fujimoto S; Hamasaki A; Fujiwara H; Fujita Y; Ikeda K; Takahara S; Nagashima K; Hosokawa M; Seino Y; Inagaki N
J Diabetes Investig; 2011 Aug; 2(4):297-303. PubMed ID: 24843502
[TBL] [Abstract][Full Text] [Related]
12. Metabolic effects of a corticosteroid-free immunosuppressive regimen in recipients of pancreatic transplant.
Luzi L; Picena Sereni L; Battezzati A; Elli A; Soulillou JP; Cantarovich D
Transplantation; 2003 Jun; 75(12):2018-23. PubMed ID: 12829904
[TBL] [Abstract][Full Text] [Related]
13. Metabolic consequences of pancreatic systemic or portal venous drainage in simultaneous pancreas-kidney transplant recipients.
Petruzzo P; Badet L; Lefrançois N; Berthillot C; Dorel SB; Martin X; Laville M
Diabet Med; 2006 Jun; 23(6):654-9. PubMed ID: 16759308
[TBL] [Abstract][Full Text] [Related]
14. [Clinical significance of measuring serum c-peptide before and after glucagon injection].
Kan Y; Chi Z
Zhonghua Yi Xue Za Zhi; 1991 Jan; 71(1):16-7, 4. PubMed ID: 1850647
[TBL] [Abstract][Full Text] [Related]
15. Simple evaluation of engraftment by secretory unit of islet transplant objects for living donor and cadaveric donor fresh or cultured islet transplantation.
Matsumoto S; Yamada Y; Okitsu T; Iwanaga Y; Noguchi H; Nagata H; Yonekawa Y; Nakai Y; Ueda M; Ishii A; Yabunaka E; Tanaka K
Transplant Proc; 2005 Oct; 37(8):3435-7. PubMed ID: 16298620
[TBL] [Abstract][Full Text] [Related]
16. Pancreas transplantation as therapy for diabetes mellitus.
Robertson RP; Sutherland DE
Annu Rev Med; 1992; 43():395-415. PubMed ID: 1580598
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional and Longitudinal Analyses of Factors Contributing to the Progressive Loss of the β-cell Function in Type 2 Diabetes.
Nakayama H; Kato T; Nakayama S; Kaku H; Muraishi K; Tokubuchi I; Hara K; Kato T; Wada N; Tsuruta M; Ohki T; Tanaka K; Mitsuzaki K; Tajiri Y; Yamada K
Intern Med; 2015; 54(16):1971-6. PubMed ID: 26278286
[TBL] [Abstract][Full Text] [Related]
18. Kidney-pancreas transplants: is it so difficult to start a program?
Alonso A; Fernández C; Villaverde P; García R; Aguirrezabalaga J; Gómez M; Oliver J; Valdés F
Transplant Proc; 2005 Apr; 37(3):1455-6. PubMed ID: 15866636
[TBL] [Abstract][Full Text] [Related]
19. Combined pancreas and kidney transplantation in a lean type 2 diabetic patient. Effects on insulin secretion and sensitivity.
Pox C; Ritzel R; Büsing M; Meier JJ; Klempnauer J; Schmiegel W; Nauck MA
Exp Clin Endocrinol Diabetes; 2002 Nov; 110(8):420-4. PubMed ID: 12518254
[TBL] [Abstract][Full Text] [Related]
20. Postprandial serum C-peptide value is the optimal index to identify patients with non-obese type 2 diabetes who require multiple daily insulin injection: Analysis of C-peptide values before and after short-term intensive insulin therapy.
Fujiwara D; Takahashi K; Suzuki T; Shii M; Nakashima Y; Takekawa S; Yoshida A; Matsuoka T
J Diabetes Investig; 2013 Nov; 4(6):618-25. PubMed ID: 24843717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
